UBS Initiates Coverage of Iovance Biotherapeutics (LSE:0JDK) with Buy Recommendation
Source: NASDAQ Stocks / 25 Oct 2024 02:47:17 America/Chicago
Fintel reports that on October 24, 2024, UBS initiated coverage of Iovance Biotherapeutics (LSE:0JDK) with a Buy recommendation.
https://www.nasdaq.com/articles/ubs-initiates-coverage-iovance-biotherapeutics-lse-0jdk-buy-recommendation